Fosfomycin for urinary tract infections in men
Part of Cancer, Genetic & congenital, Hormones & metabolism, Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a single dose of fosfomycin, an antibiotic, compared to a placebo for treating urinary tract infections in men. The goal is to see if it helps relieve symptoms and clear the infection better than no active treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older.
- You have at least one recent symptom of a urinary tract infection, like painful urination, feeling the need to urinate often or urgently, blood in the urine, or pelvic pain.
- You are not severely ill (e.g., no very low blood pressure, no extreme fever, no signs of a kidney infection).
- You have not taken antibiotics within the last 72 hours before joining.
- You do not have known urinary tract abnormalities, significant kidney disease, or recent urinary tract procedures.
- You are able to take oral medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This trial studies whether IV (through a vein) fosfomycin can treat severe bacterial infections in adults. It may help people whose infection is covered by the standard fosfomycin use and who need hospital-level care.
This trial tests an investigational drug called Fluorothiazinone for women with recurring bacterial bladder infections. If you have frequent, painful urinary symptoms, this study might help assess a new treatment option.
This trial compares a longer, higher-dose antibiotic course combined with methenamine hippurate (a urinary antiseptic) against standard care (low-dose antibiotics or methenamine alone) for women with chronic urinary tract infections. It aims to see if the extended treatment is more effective at relieving persistent symptoms.
This study tests a new way to manage urinary tract infection symptoms in women aged 65 and older. It aims to improve how symptoms are treated and reduce the number of infections.
This study compares taking a daily antibiotic (nitrofurantoin) alone versus having a procedure that cauterizes bladder areas (fulguration) plus the same daily antibiotic, to see which is better at preventing recurrent urinary tract infections in women.
Hear when a new Prostatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.